Board of Regents, The University of Texas System;Memorial Sloan-Kettering Cancer Center
发明人:
James Allison,Padmanee Sharma,Sergio A. Quezada,Tihui Fu
申请号：
US16215321
公开号：
US20190352398A1
申请日:
2018.12.10
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
